Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate dehydrogenase 1 pseudogene 3 (GLUD1P3)
- Target
- GLUD1P3
- Molecular classification
- Pseudogene, Other (not an enzyme, receptor, ion channel, etc.)
01
Overview
Glutamate dehydrogenase 1 pseudogene 3 (GLUD1P3) is a non-protein-coding pseudogene located in the human genome, related to the functional gene encoding glutamate dehydrogenase 1 (GLUD1). While some pseudogenes can have regulatory roles through their RNA transcripts (e.g., influencing the expression or stability of related protein-coding genes), there is no evidence that GLUD1P3 is involved in such mechanisms. It does not encode an enzyme, receptor, or transporter and is not associated with any diseases, biomarkers, drug interactions, or safety concerns. Therefore, GLUD1P3 should not be considered a valid drug discovery or therapeutic target[4][6][2].
- Other names
- C10orf102Em:AC022400.11GLUDP3RP11-574K11.12
02
Mechanism of action
None. There are no drugs targeting GLUD1P3, so there are no mechanisms of action.
03
Biological functions
Pseudogenes may play regulatory roles (such as influencing the stability of mRNAs of their parent genes via noncoding RNA mechanisms), but there are no specific biological functions established for GLUD1P3 itself
04
Disease associations
Other. There are no specific disease associations or roles described for GLUD1P3 itself.Pseudogenes, in general, may participate as modulators of gene expression or miRNA decoys, but evidence for GLUD1P3 in this context is lacking
Beyond the preview
Go deeper on Glutamate dehydrogenase 1 pseudogene 3 (GLUD1P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glutamate dehydrogenase 1 pseudogene 3 (GLUD1P3).